#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3868	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2539	424.9	0	.	n	.	0	C451T	SNP	451	451	C	867	867	T	528	T,C,G	302,112,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3868	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2539	424.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1600	1600	C	569	C,T	460,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	0	.	n	.	0	T695C	SNP	695	695	T	1222	1222	C	494	C,A	410,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1864	1864	A	477	A,G,T	305,94,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2498	2498	C	466	C	381	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2572	2572	A	509	A	407	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3124	3124	C	493	C,T	392,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6250	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3783	458.7	0	HET	.	.	.	C539T,G	.	539	539	C	1066	1066	C	533	C,T,G	308,100,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	444	folP	855	855	100.0	folP.l15.c4.ctg.1	1984	63.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1215	1217	AGC	100;99;99	A;G;C	79;79;79	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1302	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4039	90.2	1	SNP	p	S91F	1	.	.	271	273	TTC	820	822	TTC	92;93;92	T;T;C	79;76;76	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1302	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4039	90.2	1	SNP	p	D95G	1	.	.	283	285	GGC	832	834	GGC	89;89;88	G;G;C	74;75;73	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1302	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4039	90.2	1	SNP	p	G95N	0	.	.	283	285	GGC	832	834	GGC	89;89;88	G;G;C	74;75;73	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	504	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1713	82.8	1	SNP	p	G45D	0	.	.	133	135	GGC	598	600	GGC	120;120;120	G;G;C	93;94;93	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	266	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1442	52.1	0	.	n	.	0	A197.	DEL	197	197	A	725	725	A	105	A	86	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3385	117.5	1	SNP	p	D86N	0	.	.	256	258	GAC	772	774	GAC	159;158;162	G;A,C;C,A	132;127,1;133,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3385	117.5	1	SNP	p	R87I	0	.	.	259	261	CGT	775	777	CGT	163;163;164	C;G;T,G	130;128;127,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3385	117.5	1	SNP	p	R87W	0	.	.	259	261	CGT	775	777	CGT	163;163;164	C;G;T,G	130;128;127,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3385	117.5	1	SNP	p	S87R	1	.	.	259	261	CGT	775	777	CGT	163;163;164	C;G;T,G	130;128;127,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3385	117.5	1	SNP	p	S88P	0	.	.	262	264	TCC	778	780	TCC	163;163;163	T;C;C	131;133;133	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	956	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2984	90.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1713	1715	GGC	110;108;107	G;G,T;C	88;88,1;86	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1602	1604	GCC	118;119;119	G;C,A,T;C	97;93,1,1;98	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1605	1607	ATG	119;119;117	A;T;G	96;94;91	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1617	1619	ACC	118;118;118	A;C;C	99;99;100	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1617	1619	ACC	118;118;118	A;C;C	99;99;100	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2118	2120	ACC	118;120;121	A;C;C,A	100;102;103,1	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2172	2174	GCG	134;134;134	G;C;G	104;101;103	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2172	2174	GCG	134;134;134	G;C;G	104;101;103	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2295	2297	GGT	126;125;125	G;G,T;T	110;110,1;111	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2304	2306	AGC	126;126;126	A,C;G;C	106,1;108;107	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	976	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2862	95.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2322	2324	CCG	129;129;129	C;C;G	105;108;107	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1278	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3429	103.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1784	1786	CCG	93;93;93	C,A;C,T;G	73,1;77,1;76	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	600	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2161	77.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	86	C	73	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1390	1392	AAT	10;10;10	A;A;T	7;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1393	1395	AAT	10;10;10	A;A;T,G	8;7;7,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1417	1419	GCA	8;8;8	G;C;A	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1441	1442	TC	6;6	T;C	6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1446	1448	AAC	6;6;6	A;A;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1450	1454	TGGCG	6;6;6;6;6	T;G;G;C;G	6;6;6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1456	1458	GCT	6;6;6	G;C;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1516	1518	TTA	6;6;6	T;T;A	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1561	1563	CAT	6;6;6	C;A;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1564	1566	AGT	7;7;7	A;G;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	287	90.72	porB1a.l15.c4.ctg.1	1655	16.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1573	1575	TAC	7;7;7	T;A;C	6;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	708	710	GAA	148;146;146	G;A;A	113;118;119	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1119	1121	TCA	152;153;152	T;C,A;A	121;126,1;127	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	0	.	p	.	0	Y254S	NONSYN	760	762	TAT	1356	1358	TCT	160;159;159	T;C,T;T	133;135,1;138	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	1	SNP	p	G120K	1	.	.	358	360	AAG	954	956	AAG	143;144;144	A;A,C;G	122;120,1;123	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	1	SNP	p	D121N	0	.	.	361	363	GAC	957	959	GAC	145;145;145	G;A;C	122;124;120	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	840	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	2068	114.3	1	SNP	p	A121D	1	.	.	361	363	GAC	957	959	GAC	145;145;145	G;A;C	122;124;120	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2412	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5266	128.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	398	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1291	86.7	1	SNP	p	V57M	1	.	.	169	171	ATG	640	642	ATG	145;145;145	A;T;G	117;118;116	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
